ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
April 03, 2024 07:30 ET
|
ARCA biopharma, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company...
ARCA biopharma Announces 2023 Financial Results
February 01, 2024 16:35 ET
|
ARCA biopharma, Inc.
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma Announces Third Quarter 2023 Financial Results
October 18, 2023 16:25 ET
|
ARCA biopharma, Inc.
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma Announces Second Quarter 2023 Financial Results
July 21, 2023 16:25 ET
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE...
ARCA biopharma Announces First Quarter 2023 Financial Results
April 24, 2023 16:25 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., April 24, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
February 24, 2023 16:20 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
James Flynn Joins ARCA biopharma Board of Directors
December 19, 2022 16:05 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined its Board of Directors. “We are pleased to welcome James Flynn...
ARCA biopharma Announces Third Quarter 2022 Financial Results
October 28, 2022 16:15 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Oct. 28, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
ARCA biopharma Announces Second Quarter 2022 Financial Results
August 02, 2022 16:15 ET
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Aug. 02, 2022 (GLOBE...
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
June 21, 2022 16:05 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors. “We are pleased to welcome Jacob...